Non-Small Cell Lung Cancer
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]
Alunbrig Gets FDA Approval for Frontline ALK-Positive Lung Cancer Patients
FDA has approved Alunbrig or Brigatinib for first-line treatment of patients with ALK-positive metastatic non-small cell lung cancer, as detected by [...]
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]
Guidance on Lung Cancer Screening During COVID-19
In this time of COVID-19 pandemic, a new expert panel has provided guidance to clinicians managing lung cancer screening programs. This statement was published [...]
Researchers Identify Protein to Signal if NSCLC will Spread
Lung cancer is one of the deadliest cancers in men and women worldwide. The most prevalent form of lung cancer is non-small cell lung cancer (NSCLC). NSCLC [...]
Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. [...]
Oligometastatic Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is one of the most deadly diseases and is affecting a large number of people all over the world. In the recent years, an [...]
Lung Cancer Screenings Could Detect Signs of Heart Disease via Artificial Intelligence
According to a study presented at the annual meeting of the Radiological Society of North America, artificial intelligence could measure a common marker of [...]
Researchers Link Genetic Mutations to Improved Outcomes in Lung Cancer Patients
Researchers have presented new findings related to lung cancer at the European Society for Medical Oncology (ESMO) conference in Barcelona, Spain. These new [...]
E-Sniffer to Predict Best Lung Cancer Treatment
The researchers have developed a novel device to distinguish between those who and will not respond to immunotherapy. They have reported in the Annals of [...]
Vizimpro Recommended on NHS for Non-Small Cell Lung Cancer
Health officials have approved life-extending pill for patients with an aggressive form of lung cancer. Vizimpro has been recommended as a first-line treatment [...]
Targeted Therapy Drugs for Lung Cancer
One of the developments in lung cancer medicine is introduction of targeted treatments. Targeted therapy drugs work by targeting the cancer cells. They work by [...]
NICE Approves New Lung Cancer Treatment
Continuous researches and studies are being conducted to extend life of lung cancer patients by innovating new methods and techniques. A new research has been [...]
Stage 2 Non Small Cell Lung Cancer
Stage 2 non-small cell lung cancer is the stage where the tumor is present in lung and has spread to local lymph nodes but not further than that. Stage II [...]